JP2023529502A5 - - Google Patents
Info
- Publication number
- JP2023529502A5 JP2023529502A5 JP2022577105A JP2022577105A JP2023529502A5 JP 2023529502 A5 JP2023529502 A5 JP 2023529502A5 JP 2022577105 A JP2022577105 A JP 2022577105A JP 2022577105 A JP2022577105 A JP 2022577105A JP 2023529502 A5 JP2023529502 A5 JP 2023529502A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- patient
- composition according
- compound
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025252108A JP2026048841A (ja) | 2020-06-15 | 2025-12-16 | 心房機能不全の治療 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063039438P | 2020-06-15 | 2020-06-15 | |
| US63/039,438 | 2020-06-15 | ||
| US202063042512P | 2020-06-22 | 2020-06-22 | |
| US63/042,512 | 2020-06-22 | ||
| PCT/US2021/037230 WO2021257456A1 (en) | 2020-06-15 | 2021-06-14 | Treatment of atrial dysfunction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025252108A Division JP2026048841A (ja) | 2020-06-15 | 2025-12-16 | 心房機能不全の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023529502A JP2023529502A (ja) | 2023-07-10 |
| JP2023529502A5 true JP2023529502A5 (https=) | 2024-06-24 |
| JP7832128B2 JP7832128B2 (ja) | 2026-03-17 |
Family
ID=76845320
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577105A Active JP7832128B2 (ja) | 2020-06-15 | 2021-06-14 | 心房機能不全の治療 |
| JP2025252108A Pending JP2026048841A (ja) | 2020-06-15 | 2025-12-16 | 心房機能不全の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025252108A Pending JP2026048841A (ja) | 2020-06-15 | 2025-12-16 | 心房機能不全の治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230233545A1 (https=) |
| EP (1) | EP4164644A1 (https=) |
| JP (2) | JP7832128B2 (https=) |
| KR (1) | KR20230024977A (https=) |
| CN (1) | CN116056703A (https=) |
| AU (1) | AU2021293817A1 (https=) |
| BR (1) | BR112022025551A2 (https=) |
| CA (1) | CA3180943A1 (https=) |
| CL (1) | CL2022003548A1 (https=) |
| IL (1) | IL298885A (https=) |
| MX (1) | MX2022015488A (https=) |
| TW (1) | TW202214241A (https=) |
| WO (1) | WO2021257456A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11759640B2 (en) * | 2022-01-07 | 2023-09-19 | Xyra, Llc | Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations |
| CN116082326B (zh) * | 2022-12-16 | 2024-12-27 | 药康众拓(江苏)医药科技有限公司北京分公司 | 一种氘代吡唑磺酰甲基-哌啶异噁唑脲类化合物及其用途 |
| CN117379683B (zh) * | 2023-12-12 | 2024-02-27 | 苏州晟智医疗科技有限公司 | 反搏辅助装置、计算设备、存储介质及反搏系统 |
| CN118304374A (zh) * | 2024-04-01 | 2024-07-09 | 山东省中医药研究院附属医院 | 一种组合物在制备治疗心动过速和/或瓣膜反流药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4234017B1 (en) * | 2015-01-22 | 2026-04-15 | MyoKardia, Inc. | Preparation of 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (dcm) |
| US10758525B2 (en) * | 2015-01-22 | 2020-09-01 | MyoKardia, Inc. | 4-methylsulfonyl-substituted piperidine urea compounds |
| AU2018266199A1 (en) * | 2017-05-10 | 2019-11-07 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| DK3645002T3 (da) * | 2017-06-30 | 2024-12-16 | Amgen Inc | Fremgangsmåder til behandling af hjertesvigt med hjerte-sarkomer-aktivatorer |
| KR20220009440A (ko) * | 2019-05-19 | 2022-01-24 | 미요카디아, 인크. | 화합물 (r)-4-(1-((3-(디플루오로메틸)-1-메틸-1h-피라졸-4-일)술포닐)-1-플루오로에틸)-n-(이속사졸-3-일)피페리딘-1-카르복스아미드를 사용한 수축기 기능장애 및 감소된 박출 계수를 가진 심부전의 치료 |
-
2021
- 2021-06-14 WO PCT/US2021/037230 patent/WO2021257456A1/en not_active Ceased
- 2021-06-14 IL IL298885A patent/IL298885A/en unknown
- 2021-06-14 JP JP2022577105A patent/JP7832128B2/ja active Active
- 2021-06-14 BR BR112022025551A patent/BR112022025551A2/pt unknown
- 2021-06-14 CA CA3180943A patent/CA3180943A1/en active Pending
- 2021-06-14 US US18/001,896 patent/US20230233545A1/en active Pending
- 2021-06-14 MX MX2022015488A patent/MX2022015488A/es unknown
- 2021-06-14 KR KR1020237001177A patent/KR20230024977A/ko active Pending
- 2021-06-14 EP EP21739840.3A patent/EP4164644A1/en active Pending
- 2021-06-14 CN CN202180056887.4A patent/CN116056703A/zh active Pending
- 2021-06-14 AU AU2021293817A patent/AU2021293817A1/en active Pending
- 2021-06-15 TW TW110121782A patent/TW202214241A/zh unknown
-
2022
- 2022-12-13 CL CL2022003548A patent/CL2022003548A1/es unknown
-
2025
- 2025-12-16 JP JP2025252108A patent/JP2026048841A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023529502A5 (https=) | ||
| Kishon et al. | Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up of 22 patients | |
| EP2749282B1 (en) | Method of treating atrial fibrillation | |
| Christakis et al. | Predictors of operative survival after valve replacement | |
| JP2022535195A5 (https=) | ||
| JP2025106475A5 (https=) | ||
| JP2025523921A (ja) | 非閉塞性肥大型心筋症を治療するための方法 | |
| Sezai et al. | Efficacy of Low-Dose Continuous Infusion of α-Human Atrial Natriuretic Peptide (hANP) During Cardiac Surgery Possibility of Postoperative Left Ventricular Remodeling Effect | |
| WO2024097284A1 (en) | Mavacamten and derivatives thereof for use in treating atrial dysfunction | |
| Miyazaki et al. | Reversible left ventricular dysfunction" takotsubo" cardiomyopathy associated with hyperthyroidism | |
| Mantziari et al. | Cardiac resynchronization therapy for critically ill patients with left ventricular systolic dysfunction | |
| US11911384B2 (en) | Vasodilators for treatment of heart failure | |
| Musat et al. | Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment | |
| Magalhães et al. | Oral triiodothyronine for the prevention of thyroid hormone reduction in adult valvular cardiac surgery | |
| Morisco et al. | Lisinopril in the treatment of congestive heart failure in elderly patients: comparison versus captopril | |
| Kumar et al. | Early and midterm results of extended septal myectomy: Indian experience | |
| Berger et al. | State-of–the-Art Management of Hypertrophic Cardiomyopathy in Children | |
| BEZERRA et al. | BRADYCARDIA-TACHYCARDIA SYNDROME IN A POST-OPERATIVE CARDIAC SURGERY PATIENT | |
| WO2012020377A1 (en) | Use of dronedarone for the preparation of a medicament for rhythm- and rate-controlling in patients with atrial fibrillation | |
| Kokaji et al. | Efficacy of endoventricular circular patch plasty: will this procedure improve the prognosis of patients with ischemic cardiomyopathy? | |
| Martinez et al. | Intractable, Life-Threatening Cardiac Arrhythmias Following MCS | |
| Hosokawa et al. | Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy | |
| Novikova et al. | Disease-Modifying Therapy of Chronic Heart Failure on the Background of Heart Rhythm and Conductivity Disorders (Clinical Case) | |
| Choo et al. | Amiodarone rescue therapy for severe decompensated Heart failure initially unsuitable for β-blockers | |
| AU2014274638B2 (en) | Method of treating atrial fibrillation |